Bone Biologics Corp Watch

EX-10.1

from 8-K 9 pages Holder of Common Stock Purchase Warrants Re: Inducement Offer to Exercise Common Stock Purchase Warrants Dear Holder

12/34/56

EX-10.3

from 10-Q 2 pages Amendment to Letter Agreement

12/34/56

EX-10.2

from 10-Q 8 pages Personal and Confidential

12/34/56

EX-10.1

from 8-K 47 pages Form of Securities Purchase Agreement

12/34/56

EX-10.19

from S-1/A ~1 page Strictly Confidential Accepted and Agreed: H.C. Wainwright & Co., LLC By: /S/ Edward D. Silvera Name: Edward D. Silvera Title: Chief Operating Officer Bone Biologics Corporation By: /S/ Deina H. Walsh Name: Deina H. Walsh Title: Chief Financial Officer

12/34/56

EX-10.18

from S-1/A 9 pages Strictly Confidential

12/34/56

EX-10.17

from S-1/A 38 pages Securities Purchase Agreement

12/34/56

EX-10.2

from S-1 12 pages Form of Indemnification Agreement

12/34/56

EX-10.1

from 8-K 39 pages Securities Purchase Agreement

12/34/56

EX-10.1

from 8-K 3 pages Third Amendment to the Amended and Restated Exclusive License Agreement Uc Control Number 2019-04-0625

12/34/56

EX-10.30

from 10-K 20 pages Supply and Development Support Agreement by and Between Bone Biologics Corporation and Musculoskeletal Transplant Foundation, Inc. Dated as of March 3, 2022 Supply and Development Support Agreement

12/34/56

EX-10.28

from 10-K 3 pages Debt Conversion Agreement

12/34/56

EX-10.1

from 8-K 8 pages Material contract

12/34/56

EX-10.42

from S-1/A 41 pages Warrant Agent Agreement

12/34/56

EX-10.40

from S-1/A 2 pages Material contract

12/34/56

EX-10.39

from S-1/A 3 pages Material contract

12/34/56

EX-10.2

from 8-K 13 pages Convertible Secured Term Note

12/34/56

EX-10.1

from 8-K 6 pages Note Purchase Agreement

12/34/56

EX-10.44

from 10-K 2 pages Material contract

12/34/56

EX-10.43

from 10-K 3 pages Bone Biologics Corporation Amendment to Convertible Secured Term Notes

12/34/56